Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control

from Rx for Biotech Hosted by Podcast Host Chris Leidli

InflaRx CEO Dr. Niels Riedmann joins Rx for Biotech to discuss how the company is pioneering complement-directed therapies to control severe inflammation and autoimmune disease. We break down the science behind INF904, and why C5a is such a powerful immune driver, and how precision immunology is shaping the next wave of treatment innovation.

Episode details come from the podcast's RSS feed.

Embed this episode

Attribution link and audio player

Ready to play

Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control

0:00 35:20

No transcript yet.

Requests help us decide what to transcribe next.

Share this episode

Similar podcasts

Wild WinsDay Wild WinsDay Pump the hump with WILD WINSday 🐪💪: Your 3-minute weekly video boost for leadership, sales, marketing, and business breakthroughs to WIN the day!

Frequently asked questions

How long is this episode of Rx for Biotech?

This episode is 35 minutes long.

When was this Rx for Biotech episode published?

This episode was published on November 20, 2025.

Can I download this Rx for Biotech episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.